The conflict of safety versus access to new therapies: The FDA, clinical trial design, and neuromodulation

Neuromodulation

Volumn 15, Issue 1, 2012, Pages 1-4

  Levy, Robert M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DEPTH STIMULATION; CLINICAL RESEARCH; EDITORIAL; EPILEPSY; EVALUATION; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL DEVICE; METHODOLOGY; NERVE STIMULATION; NEUROMODULATION; QUALITY OF LIFE; SAFETY; SURGICAL TECHNIQUE;

CLINICAL TRIALS AS TOPIC; DEEP BRAIN STIMULATION; DEVICE APPROVAL; ELECTRODES, IMPLANTED; HUMANS; NEUROTRANSMITTER AGENTS; RESEARCH DESIGN; SAFETY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84856622450     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2011.00425.x     Document Type: Editorial

References (19)

1. Deer T, Bowman R, Schocket M, Kim C, Ranson M, Amirdelfan K, Raso L,. The prospective evaluation of safety and success of a new method of introducing percutaneous paddle leads and complex arrays with an epidural access system. Neuromodulation 15: 1.
2. Fisher R, Salanova V, Witt T, et al,. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010; 51: 899-908.
3. Levy R, Ruland S, Weinand M, et al,. Cortical stimulation for the rehabilitation of patients with hemiparetic stroke: a multicenter feasibility study of safety and efficacy. J Neurosurg 2008; 108: 707-714. (Pubitemid 351498966)
4. Gottlieb S,. How the FDA could cost you your life. Wall Street Journal, 2011;October 3.
5. Cavuto J,. Neurotech Report. Neuromodulation 2011; 14: 298.
6. MDDI Medical Device and Diagnostic Industry News Products and Suppliers,. A look at medical device numbers in 2011, November 21, 2011.
7. Turner J, Loeser J, Deyo R, Saunders S., Spinal cord stimulation for patients with failed back surgery or complex regional pain syndrome: A systematic review of effectiveness and complications. Pain 2004; 108: 137-147. (Pubitemid 38251683)
8. Taylor RS, Van Buyten J-P, Buchser E., Spinal cord stimulation for chronic back and leg pain and failed back surgery syndrome: a systematic review and analysis of prognostic factors. Spine 2005; 30: 152-160. (Pubitemid 40209292)
9. Coffey RJ, Lozano AM, (2006). Neurostimulation for chronic non-cancer pain: an evaluation of the clinical evidence and recommendations for future trial designs. Journal of Neurosurgery 105: 175-189.
10. Coffey RJ, Hamani C, Lozano AM,. Evidence Base: Neurostimulation for pain, in, Winn RH, ed. Youmans Neurological Surgery. 6th Ed. Philadelphia, Elsevier-Saunders, 2011, pp 1809-1820.
11. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J., Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003; 106: 337-345. (Pubitemid 37505881)
12. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J., Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005; 113: 9-19. (Pubitemid 40038441)
13. Turk DC, Dworkin RH, Burke LB, Gershon R, Rothman M, Scott J, Allen RR, Atkinson JH, Chandler J, Cleeland C, Cowan P, Dimitrova R, Dionne R, Farrar JT, Haythornthwaite JA, Hertz S, Jadad AR, Jensen MP, Kellstein D, Kerns RD, Manning DC, Martin S, Max MB, McDermott MP, McGrath P, Moulin DE, Nurmikko T, Quessy S, Raja S, Rappaport BA, Rauschkolb C, Robinson JP, Royal MA, Simon L, Stauffer JW, Stucki G, Tollett J, von Stein T, Wallace MS, Wernicke J, White RE, Williams AC, Witter J, Wyrwich KW., Developing outcome measures for pain clinical trials: IMMPACT recommendations. Pain 2006; 125: 208-215. (Pubitemid 44711972)
14. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR Stauffer JW, von Stein T, White RE, Witter J, Zavisic S., Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain 2008; 9: 105-121. (Pubitemid 351147828)
15. McGrath PJ, Walco G, Turk DC, Dworkin RH, Brown MT, Davidson K, Eccleston C, Finley GA, Goldschneider K, Haverkos L, Hertz SH, Ljungman G, Palermo T, Rappaport BA, Rhodes T, Schechter N, Scott J, Sethna N, Svensson OK, Stinson J, von Baeyer CL, Walker L, Weisman S, White RE, Zajicek A, Zeltzer L., Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. Journal of Pain 2008; 9: 771-783.
16. Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad JR, Jay GW, Jermano JA, Katz NP, Manning DC, Martin S, Max MB, McGrath P, McQuay HJ, Quessy S, Rappaport BA, Revicki DA, Rothman M, Stauffer JW, Svensson O, White RE, Witter J., Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Pain 2008; 139: 485-493.
17. Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, Farrar JT, Hertz S, Raja SN, Rappaport BA, Rauschkolb C, Sampaio C., Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain 2009; 146: 238-244.
18. Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, Chappell A, Chartier K, Cleeland CS, Costello A, Cowan P, Dimitrova R, Ellenberg S, Farrar JT, French JA, Gilron I, Hertz S, Jadad AR, Jay GW, Kalliomäki J, Katz NP, Kerns RD, Manning DC, McDermott MP, McGrath P, Narayana A, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Reeve B, Rhodes T, Sampaio C, Simpson DM, Stauffer JW, Stucki G, Tobias J, White RE, Witter J., Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain 2010; 149: 177-193.
19. Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, Gilron I, Jensen MP, Katz NP, Raja SN, Rappaport BA, Rowbotham MC, Backonja MM, Baron R, Bellamy N, Bhagwagar Z, Costello A, Cowan P, Fang WC, Hertz S, Jay GW, Junor R, Kerns RD, Kerwin R, Kopecky EA, Lissin D, Malamut R, Markman JD, McDermott MP, Munera C, Porter L, Rauschkolb C, Rice ASC, Sampaio C, Skljarevski V, Sommerville K, Stacey B, Steigerwald I, Tobias J, Trentacosti AM, Wasan AD, Wells GA, Williams J, Witter J, Ziegler D., Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Manuscript submitted for publication.